E

Emergent BioSolutions

2321 employees

Emergent BioSolutions develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats.

Basic info

Industry

biotechnology research

Sectors

Vaccine Development
Biotechnology
Contract Development and Manufacturing
Health Care
Therapeutics Development
Devices Development
M&A
Pharmaceutical
Manufacturing
Partnering
Life Science

Date founded

1998

Funding rounds raised

Total raised

$15M

from 2 investors over 2 rounds

E

Emergent BioSolutions raised undisclosed on November 14, 2022

Investors: united-states-department-of-defense

E

Emergent BioSolutions raised $15M on April 3, 2020

Investors: Biomedical Advanced Research and Development Authority (BARDA)

FAQ